Life Science Analytics Market Revenue, Growth Factors, Trends, Key Companies, Forecast To 2027

 


According to MRFR analysis, Life Science Analytics Market is expected to register a CAGR of 11.91% during the forecast period and was valued at USD 19,165.22 Million in 2018.

Life science analytics is a tool that helps in clinical trials standardization and optimization of the drug discovery process.

The growth of the global life science analytics market can be contributed to growing pressure to curb the healthcare expenditure, need for improved data standardization, and increasing prevalence of chronic diseases. Furthermore, the growing adoption of analytics solutions in clinical trials, increasing adoption of analytics tools for sales & marketing applications, the need for improved patient outcomes, and rising adoption of big data in the life science industry are also expected to fuel the market growth during the forecast period. However, high implementation costs and lack of skilled professionals have expected to restrain the growth of the global life science analytics market.

Several market players such as Allscripts Healthcare, LLC, Cerner Corporation and McKesson Corporation currently dominate the global life science analytics market. The key players are involved in product launches and acquisitions to strengthen their market positions. For instance, in January 2018, Allscripts acquired Practice Fusion for USD 100 million. This acquisition further advance Allscripts’ strategy to offer comprehensive, high performing health information technologies and solutions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2018, owing to the presence of major market players in the region. The life science analytics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European life science analytics market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The life science analytics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rapidly developing life sciences industry, the market in Asia-Pacific is expected to be the fastest-growing. The life science analytics market in the Middle East & Africa has been divided into the Middle East and Africa. As a result, there has been an increase in the consumption of life science analytics software in the area in order to reduce healthcare expenses.

Segmentation

The Global Life Science Analytics Market has been segmented based on the type of analytics, application, component, deployment model, and end-user.

Based on the type of analytics, the global life science analytics market has been segmented into predictive analytics, descriptive analytics, and prescriptive analytics. The descriptive analytics segment held the largest market share in 2018 owing to its high preferability by the life science companies, as these solutions help in understanding the past trends.

The global life science analytics market, based on application, has been segmented into research & development, pharmacovigilance, regulatory compliance, sales & marketing, and supply chain optimization. The research & development segment is further sub-segmented into clinical trials and preclinical trials. The research & development segment held the largest market share in 2018 owing to the rising usage in R&D activities for the development of innovative life science products.

The global life science analytics market has been segmented based on component, as software, services, and hardware. The software segment is held the largest market share in 2018 owing to the rising adoption of analytics software in the life science industry.

The global life science analytics market has been segmented, on the basis of deployment model, into on-premise and cloud-based. The on-premise model held the larger market share in 2018 owing to its user-friendly approach.

The market based on end-user has been segmented into hospitals & clinics, pharmaceutical, biotechnology & medical device companies, and others. Hospitals & clinics segment held the largest market share in 2018 as it helps to minimize the clinical errors and increases healthcare productivity.

Key Players

Some of the Key Players in the Global Life Science Analytics Market are Allscripts Healthcare, LLC (US), Cerner Corporation (US), CitiusTech Inc. (US), Health Catalyst (US), Inovalon (US), McKesson Corporation (US), Saama Technologies, Inc. (US), Optum, Inc. (US), SCIOInspire, Corp. (US), SAS Institute Inc. (US), IBM (US), Oracle (US), and IQVIA (US).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

Comments

Post a Comment

Popular posts from this blog

Doxorubicin Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the  doxorubicin market  are surge in geriatric population, rising prevalence of different types of cancer, increasing awareness for cancer treatment. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities. The various side effects, cost containment policies by various governments, stringent regulatory environment for product approval, are likely to hinder market growth during the forecast period. Regional Analysis The American market is expected to dominate the global doxorubicin market during the forecast period due to the presence of major manufacturers, increase in number of cancer cases, awareness ...
Read more

Chromatography Software Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
According to MRFR analysis, the global  Chromatography Software Market  is expected to register a CAGR of ~8.1% from 2022 to 2030 and hold a value of USD 15,330 million by 2030. Chromatography software is the gadget that allows chromatography-based analysis. This software system organizes and manages data from chromatography instruments, records and processes it, and generates chromatograms and reports. Data processing, instrument control, and database management are automated using this chromatography data software. Chromatography informatics solutions are available in various formats, from integrated to automated independent software platforms. These tools are employed in multiple sectors, including materials science, drug development, and forensics. The growing demand for chromatography applications in different fields, surge in the utilization of chromatography techniques in R&D activities across various industries such as the pharmaceutical industry and increasing tec...
Read more

Orthokeratology Lens Market Revenue Trends, Company Profiles, Revenue Share Analysis Till 2030

Image
The   Orthokeratology Lens Market   is expected to reach USD 3,900.8 Million by 2030 at 7.8% CAGR during the forecast period 2022-2030. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision. The increasing advancements in the field of ophthalmology over the past couple of decades, low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is anticipated to drive the market growth. However, the risk associated with orthokeratology and availability of alternative treatment methods is likely to hamper the market growth. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/8218 Segment Analysis The global ortho...
Read more